PAI
ProQuest Associates IV Portfolio holdings
AUM
$53M
This Quarter Return
+43.13%
1 Year Return
+3.35%
3 Year Return
+116.54%
5 Year Return
–
10 Year Return
–
AUM
$99.8M
AUM Growth
+$99.8M
(+28%)
Cap. Flow
-$223M
Cap. Flow
% of AUM
-223.44%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
5
New
–
Increased
–
Reduced
3
Closed
–
Top Buys
No buys this quarter
Top Sells
| 1 |
EGRX
Eagle Pharmaceuticals, Inc.
EGRX
|
$217M |
| 2 |
IMDZ
Immune Design Corp.
IMDZ
|
$5.69M |
| 3 |
UroGen Pharma
URGN
|
$49.9K |
Sector Composition
| 1 | Healthcare | 62.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
UroGen Pharma
URGN
$900M
| $45.7M | 45.77% |
1,449,745
-1,584
| -0.1% | -$49.9K |
|
|
AGRX
2
DELISTED
Agile Therapeutics, Inc
AGRX
| $22.6M | 22.62% |
5,062,363
| – | – |
|
3
Mersana Therapeutics
MRSN
$36.5M
| $16.5M | 16.55% |
955,709
| – | – |
|
|
IMDZ
4
DELISTED
Immune Design Corp.
IMDZ
| $14.6M | 14.65% |
1,413,280
-549,440
| -28% | -$5.69M |
|
|
EGRX
5
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $404K | 0.4% |
6,777
-3,645,507
| -100% | -$217M |
|